• Download
  • Contact Us
  • Careers
  • About Us
Home | Facilities | Services | Expertise | Products | Quality | Environmental, Health & Safety | News
  • API Intermediates*
  • Fine Chemicals*
>>The Current Position:主页 > English > Products >

A

  • Afatinib Intermediates

  • Ambrisentan Intermediates

  • Apremilast Intermediates

  • Atorvastatin Intermediates

  • Atropine Intermediates

B

  • Bedaquiline Intermediates

C

  • Ceftolozane Intermediates

  • Clofarabine Intermediates

D

  • Dantrolene Intermediates

  • Dasatinib Intermediates

  • Decitabine Intermediate

  • Dofetilide Intermediates

E

  • Erlotinib Intermediates

  • Esomeprazole Intermediate

  • Ethacrynic Acid Intermediate

  • Etravirine Intermediates

  • Everolimus Intermediate

I

  • Ibrutinib Intermediates

  • Icotinib Intermediates

  • Isoprenaline Intermediate

  • Ivabradine Intermediates

L

  • Lenalidomide Intermediates

  • Lurasidone Intermediates

M

  • Macitentan Intermediates

N

  • Nilotinib Intermediates

  • Nintedanib Intermediates

  • Nitisinone Intermediates

P

  • Pazopanib Intermediates

R

  • Roflumilast Intermediates

S

  • Silodosin Intermediates

T

  • Tolvaptan Intermediates

V

  • Vilazodone Intermediate


*Products currently covered by valid patents are offered for R&D purpose only.

2007-2018 Nanjing Pharmatechs Co., Ltd. All Rights Reserved.

Phone: 86 25 58392106 Fax: 86 25 58392998 苏ICP备11082432号-1